第 3 節　代謝及營養劑

Metabolic & nutrient agents

• 3.1靜脈營養輸液 Parenteral nutritions
  • 3.1.1Fat emulsion如 含glucose、lipid、amino acid及electrolytes三合一靜脈營養輸液98/12/1
  • 3.1.2Sodium glycerophosphate如 Glycophos111/1/1
• 3.2維生素 Vitamins
  • 3.2.1Mecobalamin製劑100/8/1
  • 3.2.2活性維生素D3製劑如 alfacalcidol、calcitriol110/12/1
• 3.3其他 Miscellaneous
  • 3.3.1肝庇護劑114/6/1
  • 3.3.2α-Keto acid-amino acid製劑如 Ketosteril
  • 3.3.3(刪除)107/10/1
  • 3.3.4口服鈣質補充劑oral calcium salt89/2/1
  • 3.3.5Nutrineal PD4 with 1.1% Amino Acid99/5/1
  • 3.3.6"Baxter" Extraneal Peritoneal Dialysis Solution With 7.5% Icodextrin108/8/1
  • 3.3.7Sodium bicarbonate成分之口服製劑給付規定96/12/1
  • 3.3.8Idursulfase如 Elaprase106/10/1
  • 3.3.9Imiglucerase如 Cerezyme inj.、Elelyso注射劑、VPRIV凍晶注射劑111/5/1
  • 3.3.10Laronidase如 Aldurazyme106/10/1
  • 3.3.11Miglustat如 Zavesca108/5/1
  • 3.3.12Sodium phenylacetate＋Sodium benzoate如 Ammonul inj99/2/1
  • 3.3.13Agalsidase alfa如 Replagal、Fabrazyme、Elfabrio114/2/1
  • 3.3.14Carglumic acid如 Carbaglu Tablets106/7/1
  • 3.3.15Galsulfase如 Naglazyme107/12/1
  • 3.3.16(刪除)111/5/1
  • 3.3.17Elosulfase alfa如 Vimizim、Vimizim112/7/1
  • 3.3.18Eliglustat Capsules如 Cerdelga108/5/1
  • 3.3.19先天性代謝異常之罕見疾病藥品113/11/1
  • 3.3.20Polysaccharides of Astragalus membranaceus如 PG2 Lyo. Injection110/3/1
  • 3.3.21alpha-glucosidase如 Myozyme115/6/1
  • 3.3.22CRRT non Ca dialysate111/4/1
  • 3.3.234%檸檬酸鈉溶液如 A.C.D.-4 Solution "S.T."111/4/1
  • 3.3.24Support Cal 1.47% CaCl2111/4/1
  • 3.3.25Chenodeoxycholic acid111/6/1
  • 3.3.26Alfa-avalglucosidase如 Nexviazyme112/4/1
  • 3.3.27KH2PO4+Na2HPO4+NaH2PO4．H2O如 PhosAdd Tab.112/5/1
  • 3.3.28Migalastat hydrochloride如 Galafold114/2/1
  • 3.3.29Burosumab如 Crysvita113/5/1
  • 3.3.30Glycerol phenylbutyrate如 Ravicti113/11/1
  • 3.3.31Givosiran如 Givlaari114/1/1
  • 3.3.32Maralixibat chloride如 Livmarli115/9/1